HK1059927A1 - Condensed purine derivatives as a1 adenosine receptor antagonists - Google Patents
Condensed purine derivatives as a1 adenosine receptor antagonistsInfo
- Publication number
- HK1059927A1 HK1059927A1 HK04101469.6A HK04101469A HK1059927A1 HK 1059927 A1 HK1059927 A1 HK 1059927A1 HK 04101469 A HK04101469 A HK 04101469A HK 1059927 A1 HK1059927 A1 HK 1059927A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- receptor antagonists
- adenosine receptor
- purine derivatives
- condensed purine
- condensed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25065800P | 2000-12-01 | 2000-12-01 | |
PCT/US2001/044991 WO2002044182A1 (en) | 2000-12-01 | 2001-11-30 | Condensed purine derivatives as a1 adenosine receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1059927A1 true HK1059927A1 (en) | 2004-07-23 |
Family
ID=22948640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK04101469.6A HK1059927A1 (en) | 2000-12-01 | 2004-02-27 | Condensed purine derivatives as a1 adenosine receptor antagonists |
Country Status (33)
Country | Link |
---|---|
US (2) | US6605601B2 (xx) |
EP (1) | EP1347981B1 (xx) |
JP (2) | JP2004514723A (xx) |
KR (1) | KR20040011439A (xx) |
CN (1) | CN100497340C (xx) |
AR (1) | AR035400A1 (xx) |
AT (1) | ATE394402T1 (xx) |
AU (2) | AU2002219977B2 (xx) |
BG (1) | BG107849A (xx) |
BR (1) | BR0115833A (xx) |
CA (1) | CA2430508C (xx) |
CZ (1) | CZ20031513A3 (xx) |
DE (1) | DE60133931D1 (xx) |
EA (1) | EA009814B1 (xx) |
EE (1) | EE200300260A (xx) |
ES (1) | ES2305139T3 (xx) |
GE (1) | GEP20094697B (xx) |
HK (1) | HK1059927A1 (xx) |
HU (1) | HUP0400530A3 (xx) |
IL (1) | IL156046A0 (xx) |
IS (1) | IS6821A (xx) |
MX (1) | MXPA03004857A (xx) |
MY (1) | MY127120A (xx) |
NO (1) | NO20032483L (xx) |
NZ (1) | NZ526511A (xx) |
PL (1) | PL362642A1 (xx) |
SK (1) | SK6552003A3 (xx) |
TR (1) | TR200300766T2 (xx) |
TW (1) | TWI293301B (xx) |
UA (1) | UA75625C2 (xx) |
WO (1) | WO2002044182A1 (xx) |
YU (1) | YU42903A (xx) |
ZA (2) | ZA200304067B (xx) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2238335T3 (es) * | 1999-12-24 | 2005-09-01 | Kyowa Hakko Kogyo Co., Ltd. | Derivados de purina condensados. |
DE60133931D1 (de) * | 2000-12-01 | 2008-06-19 | Biogen Idec Inc | Kondensierte purinderivate als a1-adenosinrezeptorantagonisten |
CA2516250A1 (en) * | 2003-02-19 | 2004-09-02 | Endacea, Inc. | A1 adenosine receptor antagonists |
US20040229901A1 (en) * | 2003-02-24 | 2004-11-18 | Lauren Otsuki | Method of treatment of disease using an adenosine A1 receptor antagonist |
WO2004096228A1 (en) * | 2003-04-25 | 2004-11-11 | Novacardia, Inc. | Method of improved diuresis in individuals with impaired renal function |
CN1777608A (zh) * | 2003-04-25 | 2006-05-24 | 协和发酵工业株式会社 | 稠合嘧啶衍生物 |
US7247639B2 (en) * | 2003-06-06 | 2007-07-24 | Endacea, Inc. | A1 adenosine receptor antagonists |
WO2006099204A1 (en) * | 2005-03-11 | 2006-09-21 | Aderis Pharmaceuticals, Inc. | Substituted 9-alkyladenines and the use thereof |
US7795427B2 (en) * | 2006-02-14 | 2010-09-14 | New York University | Methods for inhibiting osteoclast differentiation, formation, or function and for increasing bone mass |
CA2648281A1 (en) * | 2006-04-06 | 2007-10-18 | Novacardia, Inc. | Co-administration of adenosine a1 receptor antagonists and anticonvulsants |
CN102516241B (zh) | 2006-05-19 | 2015-07-29 | 艾伯维巴哈马有限公司 | Cns活性的稠合的双环杂环取代的氮杂双环烷烃衍生物 |
JP2009540003A (ja) * | 2006-06-16 | 2009-11-19 | ノヴァカーディア,インク. | Aa1raの低頻度投与を含む腎機能の長期間にわたる改善 |
JP5274455B2 (ja) | 2006-06-23 | 2013-08-28 | インサイト コーポレイション | Hm74aアゴニストとしてのプリノン誘導体 |
WO2007150025A2 (en) | 2006-06-23 | 2007-12-27 | Incyte Corporation | Purinone derivatives as hm74a agonists |
US20080242684A1 (en) * | 2007-03-29 | 2008-10-02 | Howard Dittrich | Methods of administration of adenosine a1 receptor antagonists |
WO2008121893A1 (en) * | 2007-03-29 | 2008-10-09 | Novacardia, Inc. | Methods of treating heart failure and renal dysfunction in individuals with an adenosine a1 receptor antagonist |
WO2011063268A2 (en) * | 2009-11-19 | 2011-05-26 | Biogen Idec Ma Inc | Novel synthetic methods |
US20130109645A1 (en) | 2010-03-31 | 2013-05-02 | The united States of America,as represented by Secretary,Dept.,of Health and Human Services | Adenosine receptor agonists for the treatment and prevention of vascular or joint capsule calcification disorders |
IL275817B2 (en) | 2018-01-04 | 2024-04-01 | Impetis Biosciences Ltd | Tricyclic compounds, preparations and their medical applications |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06102662B2 (ja) | 1989-09-01 | 1994-12-14 | 協和醗酵工業株式会社 | キサンチン誘導体 |
JP2988711B2 (ja) * | 1989-10-20 | 1999-12-13 | 協和醗酵工業株式会社 | 縮合プリン誘導体 |
KR100252493B1 (ko) | 1991-09-23 | 2000-05-01 | 플로리다 | 금속알콕시드 및 베타-락탐을 사용한 치환된 이소세린 에스테르의 제조방법 |
EP0884318A4 (en) * | 1996-10-07 | 2002-10-23 | Kyowa Hakko Kogyo Kk | CONDENSED PURINE DERIVATIVES |
WO1998057651A1 (en) * | 1997-06-18 | 1998-12-23 | Discovery Therapeutics, Inc. | Compositions and methods for preventing restenosis following revascularization procedures |
WO2000001388A1 (fr) | 1998-07-02 | 2000-01-13 | Kyowa Hakko Kogyo Co., Ltd. | Medicaments antidiabetiques |
ES2238335T3 (es) * | 1999-12-24 | 2005-09-01 | Kyowa Hakko Kogyo Co., Ltd. | Derivados de purina condensados. |
DE60133931D1 (de) * | 2000-12-01 | 2008-06-19 | Biogen Idec Inc | Kondensierte purinderivate als a1-adenosinrezeptorantagonisten |
-
2001
- 2001-11-30 DE DE60133931T patent/DE60133931D1/de not_active Expired - Lifetime
- 2001-11-30 EP EP01998550A patent/EP1347981B1/en not_active Expired - Lifetime
- 2001-11-30 WO PCT/US2001/044991 patent/WO2002044182A1/en active IP Right Grant
- 2001-11-30 YU YU42903A patent/YU42903A/sh unknown
- 2001-11-30 GE GEAP20017016A patent/GEP20094697B/en unknown
- 2001-11-30 JP JP2002546552A patent/JP2004514723A/ja active Pending
- 2001-11-30 TW TW090129678A patent/TWI293301B/zh active
- 2001-11-30 NZ NZ526511A patent/NZ526511A/en unknown
- 2001-11-30 PL PL01362642A patent/PL362642A1/xx not_active Application Discontinuation
- 2001-11-30 AT AT01998550T patent/ATE394402T1/de not_active IP Right Cessation
- 2001-11-30 CZ CZ20031513A patent/CZ20031513A3/cs unknown
- 2001-11-30 CN CNB018208711A patent/CN100497340C/zh not_active Expired - Fee Related
- 2001-11-30 MX MXPA03004857A patent/MXPA03004857A/es active IP Right Grant
- 2001-11-30 KR KR10-2003-7007322A patent/KR20040011439A/ko active IP Right Grant
- 2001-11-30 AR ARP010105594A patent/AR035400A1/es unknown
- 2001-11-30 CA CA2430508A patent/CA2430508C/en not_active Expired - Fee Related
- 2001-11-30 AU AU2002219977A patent/AU2002219977B2/en not_active Ceased
- 2001-11-30 BR BR0115833-3A patent/BR0115833A/pt not_active Application Discontinuation
- 2001-11-30 IL IL15604601A patent/IL156046A0/xx unknown
- 2001-11-30 SK SK655-2003A patent/SK6552003A3/sk not_active Application Discontinuation
- 2001-11-30 US US09/997,740 patent/US6605601B2/en not_active Expired - Fee Related
- 2001-11-30 UA UA2003066041A patent/UA75625C2/uk unknown
- 2001-11-30 AU AU1997702A patent/AU1997702A/xx active Pending
- 2001-11-30 MY MYPI20015481A patent/MY127120A/en unknown
- 2001-11-30 EE EEP200300260A patent/EE200300260A/xx unknown
- 2001-11-30 HU HU0400530A patent/HUP0400530A3/hu unknown
- 2001-11-30 ES ES01998550T patent/ES2305139T3/es not_active Expired - Lifetime
- 2001-11-30 EA EA200300629A patent/EA009814B1/ru not_active IP Right Cessation
- 2001-11-30 TR TR2003/00766T patent/TR200300766T2/xx unknown
-
2003
- 2003-05-20 IS IS6821A patent/IS6821A/is unknown
- 2003-05-26 ZA ZA200304067A patent/ZA200304067B/en unknown
- 2003-05-27 BG BG107849A patent/BG107849A/bg unknown
- 2003-05-27 US US10/446,573 patent/US7022686B2/en not_active Expired - Fee Related
- 2003-06-02 NO NO20032483A patent/NO20032483L/no not_active Application Discontinuation
-
2004
- 2004-02-27 HK HK04101469.6A patent/HK1059927A1/xx not_active IP Right Cessation
- 2004-10-28 ZA ZA200408755A patent/ZA200408755B/xx unknown
-
2009
- 2009-12-07 JP JP2009278047A patent/JP2010053148A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL152726A0 (en) | Adenosine a2a receptor antagonists | |
HUP0400530A3 (en) | Condensed purine derivatives as a1 adenosine receptor antagonists | |
HUP0401925A3 (en) | A2b adenosine receptor antagonists | |
IL161572A0 (en) | Adenosine a2a receptor antagonists | |
IL161716A0 (en) | ADENOSINE A2a RECEPTOR ANTAGONISTS | |
IL155962A0 (en) | Compounds specific to adenosine a1, a2a, and a3 receptors and uses thereof | |
HUP0401437A3 (en) | Adenosine a3 receptor agonists | |
MXPA03008967A (es) | Antagonistas receptores de 8-heteroarilo xantina adenosina a-2b. | |
HK1064097A1 (en) | Bicyclic Ä1,2,4Ü -triazole adenosine a2a receptor antagonists | |
NO20020931D0 (no) | Pyrrolo[2,3-d]pyrimidin-nukleosid-analoger | |
NO20020979D0 (no) | Selektive A2B-adenosin reseptorantagonister | |
HUP0303533A3 (en) | Adenosine a1 agonist adenosine derivatives | |
IL162444A0 (en) | Triazolo-quinolin derivatives useful as adenosine receptor ligands | |
PL370565A1 (en) | 5-methoxy-8-aryl-[1,2,4] triazolo [1,5-a] pyridine derivatives as adenosine receptor antagonists | |
AU3167402A (en) | Aminotriazolopyridiine derivatives as adenosine receptor ligands | |
EP1636230A4 (en) | ADENOSINE A1 RECEPTOR ANTAGONISTS | |
SI1401837T1 (sl) | Purinski derivati kot antagonisti adenozinskega receptorja A2B | |
AU2002320199A1 (en) | Purine derivatives as a2b adenosine receptor antagonists | |
SI1444233T1 (sl) | Antagonisti adenozinskega receptorja A2B | |
HUP0203369A3 (en) | Polycycloalkylpurines as adenosine receptor antagonists, process for their preparation and their use | |
GB0010292D0 (en) | A adenosine receptor agonists | |
SI1246623T1 (sl) | Spojine, specificne za adenozin A1, A2a in A3 receptor, in njihove uporabe | |
PL378983A1 (pl) | Pochodne ksantyny jako antagoniści receptora adenozyny A2B |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20121130 |